Key result
TAVR for severe AR in LVAD patients carries risk of subacute root and valve thrombosis.
Why the study?
Aortic regurgitation is increasingly observed with prolonged continuous-flow LVAD and is linked to higher rehospitalization and mortality, with TAVR emerging as a treatment option.
Highlights the risk of subacute aortic root and valve thrombosis following TAVR for severe AR in patients with continuous-flow LVADs.
Warrants vigilance for subacute thrombosis after TAVR in LVAD-AR patients; case report leaves optimal antithrombotic strategies open.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Beukian et al. (2021) studied this question. Transcatheter aortic valve replacement for severe aortic regurgitation in left ventricular assist device patients may be complicated by subacute aortic root and valve thrombosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on Heart failureMore from CASE